Tiffany Troso-Sandoval MD (She/Her)
Breast Cancer, Gynecologic Cancer
Physician/Founder
Join to View Full Profile
2 Barnes LnGarden City, NY 11530
Phone+1 917-647-1718
Dr. Troso-Sandoval is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Tiffany Troso-Sandoval is an oncologist providing patient education and virtual second opinions. She is a veteran of 25 years working at Memorial Sloan-Kettering Cancer. She received her medical degree from Weill Cornell Medical College of Cornell University and has been in practice 21 years. She specializes in breast cancer, gynecologic cancer and women’s health.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1999 - 2001
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1996 - 1999
Weill Cornell MedicineClass of 1996
Princeton UniversityA.B., Molecular Biology, 1987 - 1991
Certifications & Licensure
FL State Medical License 2022 - Present
NY State Medical License 1997 - 2026
NJ State Medical License 2020 - 2025
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsA Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor-Positive Advanced or Recurrent Endometrial Cancer.Angela K Green, Qin Zhou, Alexia Iasonos, William A Zammarrelli, Britta Weigelt
Clinical Cancer Research. 2024-11-19 - 4 citationsNivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses.Claire F Friedman, Beryl L Manning-Geist, Qin Zhou, Tara Soumerai, Aliya Holland
Nature Medicine. 2024-05-01 - 3 citationsA phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2).Melissa Lumish, M Herman Chui, Qin Zhou, Alexia Iasonos, Debra Sarasohn
Gynecologic Oncology. 2024-03-01
Press Mentions
Breakthrough: Cancer Cells Have a Molecular 'Switch' That Could Be Rewired to Behave NormallyFebruary 12th, 2025- Cancer Breakthrough as Scientists Discover ‘Switch’ That Reverses DiseaseFebruary 7th, 2025
- Cancer Breakthrough as Scientists Discover 'Switch' That Reverses DiseaseFebruary 7th, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
